| All | No AKI | AKIN stage 1 | AKIN stage 2 | AKIN stage 3 | P¶ |
---|---|---|---|---|---|---|
 | (n = 140) | (n = 34) | (n = 47) | (n = 36) | (n = 23) |  |
Baseline SCr (μmol/L) (median [IQR]) | 92 (81–110) | 89 (80–103) | 98 (83–118) | 87 (80–112) | 100 (85–124) | 0.12 |
Baseline eGFR < 60 mL/min/1.73 m2 (no, %) | 50 (35.5) | 11 (26.2) | 20 (42.6) | 12 (38.7) | 7 (33.3) | 0.424 |
Baseline eGFR (mL/min/1.73Â m2) (mean [SD]) | 65 (21) | 71 (19) | 60 (22) | 67 (21) | 63 (18) | 0.078 |
Urine output (24Â hr) (mL) (mean [SD]) | 1642 (1165) | 1970 (852) | 1809 (1315) | 1357 (1234) | 1266 (978) | 0.04 |
Oliguria (< 400 mL/24 hr) (n, %) | 16 (11.5) | 0 (0) | 3 (6.5) | 8 (22.2) | 5 (21.7) | 0.003 |
Peak SCr (μmol/L) (median [IQR]) | 169 (123–277) | 102 (90–122) | 155 (135–190) | 219 (175–262) | 460 (358–460) | 0.0001 |
Delta SCr (baseline to peak) (μmol/L) (median [IQR]) | 77 (31–139) | 15 (4–22) | 55 (42–80) | 127 (94–148) | 370 (278–464) | 0.0001 |
Time to Peak SCr (d) (median [IQR]) | 1 (0–5) | - | 1 (0–2) | 1 (0–3) | 6 (2–15) | 0.0001 |
RRT (n, %) | 19 (13.6) | 0 (0) | 2 (4.3) | 4 (11.1) | 13 (56.5) | < 0.001 |
Discharge SCr (μmol/L) (median [IQR]) | 107 (83–184) | 82 (73–90) | 108 (86–108) | 112 (83–194) | 244 (148–412) | 0.0001 |
Discharge SCr* (μmol/L) (median [IQR]) | 87 (79–112) | 82 (73–90) | 96 (85–112) | 85 (73–112) | 168 (116–278) | 0.0001 |
Delta SCr (baseline to discharge)* (μmol/L) (median [IQR]) | 1 (−9 – 16) | 6 (−9 – 13) | 0 (−2 – 26) | 24 (0–96) | 92 (42–189) | 0.0001 |
RRT at hospital discharge (n, %) | 4 (17.4) | 0 (0) | 0 (0) | 0 (0) | 4 (17.4) | 0.001 |
ICU Mortality (n, %) | 30 (21.4) | 0 (0) | 11 (23.4) | 12 (33.3) | 7 (30.4) | < 0.001 |
Hospital Mortality (n, %) | 38 (27.1) | 0 (0) | 13 (27.6) | 14 (38.9) | 11 (47.8) | < 0.001 |
ICU stay (d) (median [IQR]) | 4 (2–9) | 3 (2–5) | 3 (1–7) | 4 (2–10) | 14 (7–23) | < 0.001 |
Hospital stay (d) (median [IQR]) | 11 (7–19) | 9 (7–11) | 10 (7–16) | 11 (3–24) | 23 (13–32) | < 0.001 |